Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GPN | CTAS |
|---|---|---|
| Price | $80.72 | $194.95 |
| Change today | ▼ 1.16% | ▼ 0.06% |
| Market cap | $21.36B | $77.89B |
| Return, 3 months | +7.9% | +12.2% |
| Return, year to date | +5.3% | +4.4% |
| Return, 1 year | -3.9% | -3.3% |
| P/E (TTM) | -26.6 | 38.5 |
| P/B | 0.9 | 15.0 |
| P/E percentile vs own 5y | 13th | 44th |
| Dividend yield | 1.24% | 0.96% |
| Revenue growth (YoY, latest qtr) | +68.6% | +8.9% |
| Net profit growth (YoY) | -88.2% | +14.0% |
| Gross margin | 63.9% | 50.7% |
| Operating margin | 9.8% | 23.3% |
| Net margin | -9.2% | 17.7% |
| Return on equity | -4.1% | 40.6% |
| Analyst target vs. price | +31.0% | +13.4% |
| Analyst buy share | 45% | 75% |
| RSI (14) | 36 | 43 |
| 30-day volatility | 25.0% | 15.1% |
| Max drawdown, 1 year | -29.0% | -20.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
